Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer

Sponsor
Alliance for Clinical Trials in Oncology (Other)
Overall Status
Completed
CT.gov ID
NCT00068328
Collaborator
National Cancer Institute (NCI) (NIH)
1,706
85
160
20.1
0.1

Study Details

Study Description

Brief Summary

RATIONALE: Studying how older women make treatment decisions and how these decisions affect the outcome of treatment may help doctors plan more effective treatments and improve patient quality of life.

PURPOSE: This clinical trial is studying how a patient's treatment preferences and decisions about chemotherapy affect the outcome of treatment in older women with newly diagnosed breast cancer.

Condition or Disease Intervention/Treatment Phase
  • Procedure: psychosocial assessment and care
  • Procedure: quality-of-life assessment

Detailed Description

OBJECTIVES:
  • Determine the relationship between preferences and chemotherapy decisions in women age 65 and over with operable, newly diagnosed breast cancer.

  • Determine how factors that could be targets for intervention affect the relationship between preferences and chemotherapy decisions in these patients.

  • Determine the relationships between preference-based chemotherapy decisions, quality of life, and satisfaction with treatment decisions in these patients.

  • Determine the disease-free survival and competing causes of mortality of these patients.

  • Determine the types of physician providers who care for older breast cancer survivors after initial cancer treatment is completed and explore how women decide about which physicians to see.

  • Measure quality indicators for the survivorship phase of care and evaluate if quality varies by type of physician provider model.

  • Determine if long-term patient-reported satisfaction varies as a function of physician model for providing follow-up care post-treatment.

  • Determine whether physician-patient communication and coordination of care after treatment ends mediate follow-up quality and outcomes post-treatment.

OUTLINE: This is a cohort study.

Patients participate in interviews over 30-45 minutes at baseline, at 6 months, and at 1 and 2 years.

Patients are followed annually for at least 5 years.

PROJECTED ACCRUAL: A total of 1,296 patients will be accrued for this study within 18-24 months.

Study Design

Study Type:
Observational
Actual Enrollment :
1706 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Study Start Date :
Aug 1, 2003
Actual Primary Completion Date :
Dec 1, 2006
Actual Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Group 1

Patients participate in interviews over 30-45 minutes at baseline, at 6 months, and at 1 and 2 years. Patients are followed annually for at least 5 years.

Procedure: psychosocial assessment and care

Procedure: quality-of-life assessment

Outcome Measures

Primary Outcome Measures

  1. quality of life [Up to 5 years]

Secondary Outcome Measures

  1. disease free survival [Up to 5 years]

  2. mortality rate [Up to 5 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
  • Histologically confirmed primary adenocarcinoma of the breast

  • Operable disease

  • Invasive and unilateral tumor

  • No more than 20 weeks since diagnosis

  • T1-4 (tumor size ≥ 1 cm), N0, M0 OR

  • T1-4, N1-3, M0

  • No prior carcinoma in situ, lobular carcinoma in situ, ductal carcinoma in situ, or invasive breast cancer

  • Hormone receptor status:

  • Any estrogen receptor status

PATIENT CHARACTERISTICS:

Age

  • 65 and over

Sex

  • Female

Other

  • No other malignancy except those for which the patient has completed treatment AND is considered to be at less than 30% risk of recurrence

  • History of non-melanoma skin cancer allowed

  • Sufficient cognitive function to consent to and complete interviews

  • English or Spanish speaking

Contacts and Locations

Locations

Site City State Country Postal Code
1 Camino Medical Group - Treatment Center Mountain View California United States 94040
2 Palo Alto Medical Foundation Palo Alto California United States 94301
3 Pismo Beach California United States 93449
4 Bendheim Cancer Center at Greenwich Hospital Greenwich Connecticut United States 06830
5 Washington Cancer Institute at Washington Hospital Center Washington, D.C. District of Columbia United States 20010
6 Walter Reed Army Medical Center Washington, D.C. District of Columbia United States 20307-5001
7 Cancer Center of South Florida Foundation, Incorporated Lake Worth Florida United States 33461
8 University of Chicago Cancer Research Center Chicago Illinois United States 60637-1470
9 Louis A. Weiss Memorial Hospital Chicago Illinois United States 60640
10 La Grange Memorial Hospital La Grange Illinois United States 60525
11 Center for Cancer Care at OSF Saint Anthony Medical Center Rockford Illinois United States 61108
12 Elkhart Clinic, LLC Elkhart Indiana United States 46514-2098
13 Michiana Hematology-Oncology, PC - Elkhart Elkhart Indiana United States 46514
14 Elkhart General Hospital Elkhart Indiana United States 46515
15 Howard Community Hospital Kokomo Indiana United States 46904
16 Center for Cancer Therapy at LaPorte Hospital and Health Services La Porte Indiana United States 46350
17 Suniti Medical Corporation Merrillville Indiana United States 46410
18 Michiana Hematology-Oncology, PC - South Bend Mishawaka Indiana United States 46545-1470
19 Saint Joseph Regional Medical Center Mishawaka Indiana United States 46545-1470
20 Michiana Hematology Oncology PC - Plymouth Plymouth Indiana United States 46563
21 CCOP - Northern Indiana CR Consortium South Bend Indiana United States 46601
22 Memorial Hospital of South Bend South Bend Indiana United States 46601
23 South Bend Clinic South Bend Indiana United States 46617
24 Michiana Hematology Oncology PC - La Porte Westville Indiana United States 46391
25 Maine Center for Cancer Medicine and Blood Disorders - Scarborough Scarborough Maine United States 04074
26 Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center Baltimore Maryland United States 21237
27 Sturdy Memorial Hospital Attleboro Massachusetts United States 02703
28 Massachusetts General Hospital Boston Massachusetts United States 02114
29 Dana-Farber/Brigham and Women's Cancer Center Boston Massachusetts United States 02115
30 Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute Boston Massachusetts United States 02115
31 Addison Gilbert Hospital Gloucester Massachusetts United States 01930
32 Cape Cod Hospital Hyannis Massachusetts United States 02601
33 Lowell General Hospital Lowell Massachusetts United States 01854
34 Battle Creek Health System Cancer Care Center Battle Creek Michigan United States 49017
35 Mecosta County Medical Center Big Rapids Michigan United States 49307
36 Butterworth Hospital at Spectrum Health Grand Rapids Michigan United States 49503
37 CCOP - Grand Rapids Grand Rapids Michigan United States 49503
38 Lacks Cancer Center at Saint Mary's Health Care Grand Rapids Michigan United States 49503
39 Mercy General Health Partners Muskegon Michigan United States 49443
40 Michiana Hematology Oncology PC - Niles Niles Michigan United States 49120
41 Lakeland Regional Cancer Care Center - St. Joseph Saint Joseph Michigan United States 49085
42 Lakeside Cancer Specialists, PLLC Saint Joseph Michigan United States 49085
43 Munson Medical Center Traverse City Michigan United States 49684
44 Metro Health Hospital Wyoming Michigan United States 49519
45 Saint Luke's Hospital Chesterfield Missouri United States 63017
46 Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri United States 65203
47 Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis Missouri United States 63110
48 St. Anthony's Cancer Center Saint Louis Missouri United States 63128
49 Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center Grand Island Nebraska United States 68803
50 Callahan Cancer Center at Great Plains Regional Medical Center North Platte Nebraska United States 69103
51 UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha Nebraska United States 68198-6805
52 University Medical Center of Southern Nevada Las Vegas Nevada United States 89102
53 CCOP - Nevada Cancer Research Foundation Las Vegas Nevada United States 89106
54 New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care Concord New Hampshire United States 03301
55 Center for Cancer Care at Exeter Hospital Exeter New Hampshire United States 03833
56 New Hampshire Oncology - Hematology, PA - Hooksett Hooksett New Hampshire United States 03106
57 Lakes Region General Hospital Laconia New Hampshire United States 03246
58 Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon New Hampshire United States 03756-0002
59 Norris Cotton Cancer Center at Catholic Medical Center Manchester New Hampshire United States 03102
60 Elliot Regional Cancer Center at Elliot Hospital Manchester New Hampshire United States 03103
61 Foundation Medical Partners Nashua New Hampshire United States 03060
62 Oncology Center at St. Joseph Hospital Nashua New Hampshire United States 03060
63 St. Barnabas Medical Center Cancer Center Livingston New Jersey United States 07039
64 Roswell Park Cancer Institute Buffalo New York United States 14263-0001
65 CCOP - Hematology-Oncology Associates of Central New York East Syracuse New York United States 13057
66 Queens Cancer Center of Queens Hospital Jamaica New York United States 11432
67 Memorial Sloan-Kettering Cancer Center New York New York United States 10065
68 Lipson Cancer and Blood Center at Rochester General Hospital Rochester New York United States 14621
69 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina United States 27599-7295
70 Duke Comprehensive Cancer Center Durham North Carolina United States 27710
71 Cape Fear Valley Medical Center Cancer Center Fayetteville North Carolina United States 28302-2000
72 Maria Parham Medical Center Henderson North Carolina United States 27536
73 Southeastern Regional Medical Center Lumberton North Carolina United States 28359
74 Granville Medical Center Oxford North Carolina United States 27565
75 FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center Pinehurst North Carolina United States 28374
76 Duke Health Raleigh Hospital Raleigh North Carolina United States 27609
77 Person Memorial Hospital Roxboro North Carolina United States 27573
78 Marion L. Shepard Cancer Center at Beaufort County Hospital Washington North Carolina United States 27889
79 Keyserling Cancer Center at Beaufort Memorial Hospital Beaufort South Carolina United States 29902
80 South Carolina Oncology Associates, PA Columbia South Carolina United States 29210
81 Coastal Cancer Center - Myrtle Beach Myrtle Beach South Carolina United States 29572
82 Mountainview Medical Berlin Corners Vermont United States 05602
83 Fletcher Allen Health Care - University Health Center Campus Burlington Vermont United States 05401
84 Medical Oncology and Hematology Associates of North Virginia - Fairfax Fairfax Virginia United States 22031
85 St. Mary's Regional Cancer Center at St. Mary's Medical Center Huntington West Virginia United States 25702

Sponsors and Collaborators

  • Alliance for Clinical Trials in Oncology
  • National Cancer Institute (NCI)

Investigators

  • Study Chair: Jeanne Mandelblatt, MD, MPH, Lombardi Comprehensive Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alliance for Clinical Trials in Oncology
ClinicalTrials.gov Identifier:
NCT00068328
Other Study ID Numbers:
  • CALGB-369901
  • CALGB-369901
  • CDR0000321396
First Posted:
Sep 11, 2003
Last Update Posted:
Aug 8, 2017
Last Verified:
Aug 1, 2017

Study Results

No Results Posted as of Aug 8, 2017